SUPN insider sale notice: 8,588 shares by option exercise on 09/30/2025
Rhea-AI Filing Summary
Form 144 filing for SUPN reports a proposed sale of 8,588 shares of common stock to be executed through Morgan Stanley Smith Barney LLC on 09/30/2025 on NASDAQ with an aggregate market value of $408,788.80. The filing states these shares were acquired and will be paid for on 09/30/2025 by exercise of stock options from the issuer. The document also lists multiple recent Rule 10b5-1 sales by Jack A. Khattar totaling numerous transactions in August and September 2025, including sales on 09/29/2025, 09/23/2025, 09/22/2025, and earlier dates, each showing amounts and gross proceeds. The filing shows total shares outstanding of 56,073,088, providing context for the size of the proposed sale within the company's capitalization.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider option exercise and small proposed sale versus total shares outstanding; appears procedural and compliance-focused.
The filing documents an officer or insider exercising stock options and proposing to sell 8,588 shares valued at $408,788.80 on 09/30/2025 via Morgan Stanley Smith Barney LLC. With 56,073,088 shares outstanding, this block represents a very small percentage of float. The filing also discloses multiple recent 10b5-1 sales by Jack A. Khattar across August–September 2025, indicating scheduled, pre-planned dispositions rather than ad hoc large divestitures. From a market-impact perspective, the size and nature of the transactions suggest limited immediate pricing pressure. This is a routine disclosure required by Rule 144 and contains no operating results or forward-looking items.
TL;DR: Proper Rule 144 notice and 10b5-1 sales shown; disclosure aligns with compliance expectations for insider transactions.
The form includes the required representation that the selling person does not possess undisclosed material adverse information and references adoption of trading plans where applicable. Multiple 10b5-1 sales are itemized with dates and gross proceeds, demonstrating adherence to pre-established plan mechanics. There are no indications in this filing of unusual governance events, acceleration clauses, or extraordinary insider transfers. The filing serves its compliance purpose but does not provide information on motives, compensation arrangements, or broader governance implications beyond standard insider sales reporting.